» Articles » PMID: 38566930

The Multi-faceted Nature of Age-associated Osteoporosis

Overview
Journal Bone Rep
Date 2024 Apr 3
PMID 38566930
Authors
Affiliations
Soon will be listed here.
Abstract

Age-associated osteoporosis (AAOP) poses a significant health burden, characterized by increased fracture risk due to declining bone mass and strength. Effective prevention and early treatment strategies are crucial to mitigate the disease burden and the associated healthcare costs. Current therapeutic approaches effectively target the individual contributing factors to AAOP. Nonetheless, the management of AAOP is complicated by the multitude of variables that affect its development. Main intrinsic and extrinsic factors contributing to AAOP risk are reviewed here, including mechanical unloading, nutrient deficiency, hormonal disbalance, disrupted metabolism, cognitive decline, inflammation and circadian disruption. Furthermore, it is discussed how these can be targeted for prevention and treatment. Although valuable as individual targets for intervention, the interconnectedness of these risk factors result in a unique etiology for every patient. Acknowledgement of the multifaceted nature of AAOP will enable the development of more effective and sustainable management strategies, based on a holistic, patient-centered approach.

Citing Articles

The potential link between the development of Alzheimer's disease and osteoporosis.

Nasme F, Behera J, Tyagi P, Debnath N, Falcone J, Tyagi N Biogerontology. 2025; 26(1):43.

PMID: 39832071 DOI: 10.1007/s10522-024-10181-z.


Incidence of Total Knee Arthroplasty in Older Females with Knee Osteoarthritis and Osteoporosis Treated with Denosumab Compared with Those Treated Using Bisphosphonates: A Population-Based Cohort Study.

Yu T, Wu W, Lee R, Chen I, Wang J, Wen S Life (Basel). 2025; 14(12.

PMID: 39768410 PMC: 11677198. DOI: 10.3390/life14121704.


Enhancing screening rates for bone health management in prostate cancer patients on androgen deprivation therapy with an automated outpatient system.

Wang C, Wang S, Chen C, Hung S, Chen C, Yang C Sci Rep. 2024; 14(1):28460.

PMID: 39558010 PMC: 11574127. DOI: 10.1038/s41598-024-79888-w.


From Genomics to Metabolomics: Molecular Insights into Osteoporosis for Enhanced Diagnostic and Therapeutic Approaches.

Li Q, Wang J, Zhao C Biomedicines. 2024; 12(10).

PMID: 39457701 PMC: 11505085. DOI: 10.3390/biomedicines12102389.


From gut to bone: deciphering the impact of gut microbiota on osteoporosis pathogenesis and management.

Hao L, Yan Y, Huang G, Li H Front Cell Infect Microbiol. 2024; 14:1416739.

PMID: 39386168 PMC: 11461468. DOI: 10.3389/fcimb.2024.1416739.


References
1.
Teissier T, Boulanger E, Cox L . Interconnections between Inflammageing and Immunosenescence during Ageing. Cells. 2022; 11(3). PMC: 8834134. DOI: 10.3390/cells11030359. View

2.
Lips P . Vitamin D physiology. Prog Biophys Mol Biol. 2006; 92(1):4-8. DOI: 10.1016/j.pbiomolbio.2006.02.016. View

3.
Nakamura T, Nakamura W, Yamazaki S, Kudo T, Cutler T, Colwell C . Age-related decline in circadian output. J Neurosci. 2011; 31(28):10201-5. PMC: 3155746. DOI: 10.1523/JNEUROSCI.0451-11.2011. View

4.
von Stengel S, Kemmler W, Engelke K, Kalender W . Effects of whole body vibration on bone mineral density and falls: results of the randomized controlled ELVIS study with postmenopausal women. Osteoporos Int. 2010; 22(1):317-25. DOI: 10.1007/s00198-010-1215-4. View

5.
Bonewald L . Mechanosensation and Transduction in Osteocytes. Bonekey Osteovision. 2007; 3(10):7-15. PMC: 1847717. DOI: 10.1138/20060233. View